Keel Point’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $756K | Buy |
10,814
+4,284
| +66% | +$299K | 0.05% | 219 |
|
|
2025
Q1 | $480K | Sell |
6,530
-10
| -0.2% | -$735 | 0.04% | 263 |
|
|
2024
Q4 | $428K | Sell |
6,540
-77
| -1% | -$5.05K | 0.03% | 261 |
|
|
2024
Q3 | $516K | Buy |
6,617
+7
| +0.1% | +$545 | 0.04% | 233 |
|
|
2024
Q2 | $551K | Buy |
6,610
+783
| +13% | +$65.3K | 0.05% | 212 |
|
|
2024
Q1 | $395K | Buy |
5,827
+785
| +16% | +$53.2K | 0.04% | 242 |
|
|
2023
Q4 | $340K | Buy |
5,042
+137
| +3% | +$9.23K | 0.04% | 242 |
|
|
2023
Q3 | $332K | Sell |
4,905
-956
| -16% | -$64.7K | 0.05% | 223 |
|
|
2023
Q2 | $419K | Sell |
5,861
-429
| -7% | -$30.7K | 0.06% | 191 |
|
|
2023
Q1 | $437K | Sell |
6,290
-407
| -6% | -$28.3K | 0.06% | 176 |
|
|
2022
Q4 | $454K | Buy |
6,697
+617
| +10% | +$41.8K | 0.07% | 175 |
|
|
2022
Q3 | $333K | Buy |
6,080
+59
| +1% | +$3.23K | 0.06% | 176 |
|
|
2022
Q2 | $399K | Buy |
6,021
+687
| +13% | +$45.5K | 0.06% | 169 |
|
|
2022
Q1 | $354K | Sell |
5,334
-281
| -5% | -$18.6K | 0.05% | 184 |
|
|
2021
Q4 | $327K | Buy |
5,615
+152
| +3% | +$8.85K | 0.04% | 193 |
|
|
2021
Q3 | $328K | Buy |
5,463
+799
| +17% | +$48K | 0.04% | 185 |
|
|
2021
Q2 | $279K | Sell |
4,664
-1,051
| -18% | -$62.9K | 0.03% | 205 |
|
|
2021
Q1 | $284K | Buy |
+5,715
| New | +$284K | 0.03% | 202 |
|